The largest database of trusted experimental protocols

Platelia aspergillus

Manufactured by Bio-Rad
Sourced in France

The Platelia Aspergillus is a diagnostic kit designed for the detection of Aspergillus galactomannan antigen in human serum and bronchoalveolar lavage fluid samples. It is used as an aid in the diagnosis of invasive aspergillosis.

Automatically generated - may contain errors

7 protocols using platelia aspergillus

1

HPLC-MS/MS Method for Galactomannan Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The developed method was applied to serum samples provided by the Hospital de Clínicas-UFPR. The provided samples were stored in a freezer at −40°C until analysis. All samples were identified by the hospital as negative or positive according to the results of the ELISA for galactomannans (Platelia™ Aspergillus, BioRad). The developed HPLC-MS/MS method was applied to 30 samples, including 10 that were positive and 20 that were negative for the presence of galactomannans. The results of the ELISA provided by the hospital were used as a reference to compare the results obtained by the developed HPLC-MS/MS method.
+ Open protocol
+ Expand
2

Serum Aspergillus Antigen and Antibody Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum Aspergillus galactomannan antigen level was measured with a sandwich enzyme-linked immunosorbent assay (ELISA) (Platelia™ Aspergillus; Bio-Rad Laboratories, Redmond, WA) at SRL Inc. (Tokyo, Japan). In some patients, Aspergillus IgG antibody level and Aspergillus IgE antibody level (cut-off ≥RAST class 2, corresponding to >0.07 UA/ml) [17 (link)] was measured by the Ouchterlony method and the ImmunoCAP FEIA method, respectively, also at SRL Inc.
Pulmonary function tests (PFTs) were performed in accordance with American Thoracic Society guidelines [18 (link)] using a Chestac-8900 system (Chest, Tokyo, Japan). The severity of airflow limitation was categorized as per GOLD guidelines [1 (link)].
+ Open protocol
+ Expand
3

Galactomannan Screening for Invasive Pulmonary Aspergillosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum from all patients at risk of invasive pulmonary aspergillosis (IPA) was screened twice weekly for galactomannan (Platelia Aspergillus, Biorad, Marne la Coquette, France) during the patient's ICU stay. The threshold was 0.5, according to the revised European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria [31 (link)]. If the patients had a broncho-alveolar lavage, a galactomannan assay was performed systematically at the same time as the culture.
+ Open protocol
+ Expand
4

Serum Aspergillus GM Antigen Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood samples were collected using heparin anticoagulant blood collection tubes (Becton, Dickinson and Company, USA) then sera were isolated by centrifugation at 4000 rpm for 10 min. Serum GM antigen levels were measured using a commercial sandwich enzyme-linked immunosorbent assay (ELISA) kit (Platelia™ Aspergillus; Bio-Rad, CA). An optical density (OD) index value of ≥0.5 was interpreted as a positive result.
+ Open protocol
+ Expand
5

SARS-CoV-2 and Aspergillus Diagnostics

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS‐CoV‐2 PCR was performed by in‐house PCR or by Cepheids GeneXpert Xpress SARS‐CoV‐2 PCR as described by Wolters et al.24 Triazole susceptibility screening was done using VIPcheck™ (Mediaproducts BV). MICs of Aspergillus fumigatus isolates were determined with broth microdilution using CLSI standards.25 Fungal PCR targeting the Cyp51A gene was done using AsperGenius™ (PathoNostics). 1‐3 β‐d‐glucan (BDG) testing was done using the Fungitell assay (Associates of Cape Cod Inc). Galactomannan (GM) testing was done using Platelia Aspergillus (Bio‐Rad) and/or Aspergillus lateral flow device (AspLFD, OLM Diagnostics).
+ Open protocol
+ Expand
6

Galactomannan ELISA for Aspergillus Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The GM-ELISA (Platelia Aspergillus; Bio-Rad, Edmonds, WA) was performed on positive BAL samples, according to the manufacturer's recommendations.18 (link) Briefly, 100 μL of the Platelia treatment solution was added to 300 μL of the BAL specimen and heated at 100 °C for 3 min before undergoing centrifugation. The supernatant and the horseradish peroxidase-labeled monoclonal antibody (EBA-2) were incubated at 37 °C in antibody-precoated microplates. The plates were washed and then incubated with a substrate chromogen reaction solution. The reaction was stopped by the use of 100 μL of sulfuric acid and after 30 min, the optical density (OD value) of each well was read using a microplate reader at 450 nm. One well for the negative control, two wells for the cut-off control, and one well for the positive control were used. The results of Galactomannan ELISA assay are expressed as “galactomannan index” (GMI = OD sample/mean OD cut-off control), by comparison to the “cutoff” control. A GMI index of ≥1.0 in two consecutive samples was considered positive.
+ Open protocol
+ Expand
7

Sandwich ELISA for BAL GM Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sandwich ELISA for BAL GM detection (Platelia Aspergillus ® ; Bio-Rad, Marnes-la-Coquette, France) was performed according to the manufacturer's recommendations, on a 390µL aliquot of BAL sample. For the classification of patients, the BAL was considered as positive when optical density index (ODI) was≥ 0.8, if concomitant serum GM was positive (ODI ≥0.5), and ≥1.0 when serum GM was negative or unavailable.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!